{"database": "lobbying", "table": "lobbying_activities", "rows": [[3233228, "2e974ce4-4284-4b67-b9f7-c20e02837748", "Q3", "STUMPTOWN STRATEGIES", 401106433, "PRIME THERAPEUTICS", 2024, "third_quarter", "PHA", "Introduction to Prime to Members of the 118th Congress Monitoring PBM Legislation", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-10-07T18:31:05-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3233228"], "units": {}, "query_ms": 9.320975048467517, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}